Pfizer Inc stock downgraded to Buy CandidateStockInvest.us, 1 month ago
The Pfizer Inc stock price fell by -2.96% on the last day (Monday, 29th Nov 2021) from $54.00 to $52.40. During the day the stock fluctuated 6.89% from a day low at $52.11 to a day high of $55.70. The price has fallen in 6 of the last 10 days, but is still up by 5.37% over the past 2 weeks. Volume has increased on the last day by 6 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 72 million shares were bought and sold for approximately $3.78 billion.
On Nov 29, 2021 "Morgan Stanley" gave "$50.00 - $60.00" rating for PFE. The price target was set to $54.41+0.8%.
The stock lies in the upper part of a wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $54.09 will firstly indicate a stronger rate of rising.Given the current short-term trend, the stock is expected to rise 11.5% during the next 3 months and, with a 90% probability hold a price between $48.93 and $60.31 at the end of this 3-month period.
The Pfizer Inc stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $51.68 and $46.29. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, November 26, 2021, and so far it has fallen -2.96%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
On the downside, the stock finds support just below today's level from accumulated volume at $48.61 and $48.33.There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Pfizer Inc finds support just below today's level at $48.61. If this is broken, then the next support from accumulated volume will be at $48.33 and $45.45.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $3.59 between high and low, or 6.89%. For the last week, the stock has had a daily average volatility of 3.15%.
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Pfizer Inc stock to perform well in the short-term.Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Buy candidate.Check full Pfizer Inc forecast and analysis here.